-
Podcast: Inosine May Hold Potential for Parkinson’s Disease, but Patients Urged to Act with Caution
December 23, 2013
… Today the Parkinson Study Group published in JAMA Neurology … One quick, very important note: Inosine is available commercially as a dietary supplement, but patients should … Iverson about the study and next steps. “Preliminary data from the study certainly have been supportive of the …
-
Trouble Sleeping? What to Know about Acting Out Dreams and Other Sleep Issues (Webinar Replay)
March 22, 2023
… even fall out of bed. In some, this sleep problem is linked to Parkinson’s and other brain diseases. In this audio from … Webinar, expert panelists discuss sleep issues that can come with aging and Parkinson’s and share practical tips for … a review on iTunes. It helps listeners like you find and support our mission. In this podcast, moderator Karen …
-
Targeting Lipid Biology in Stem Cell-derived Neurons to Develop a New Therapeutic Drug for Parkinson’s Disease
… for identifying potentially disease-modifying therapeutic compounds. We previously undertook a screen of 4000 compounds in human PD neurons and identified multiple molecules targeting an exciting potential drug target involved in lipid …
-
Strengthening Evidence-based Regulatory Decision-making to Address the Impact of Pesticides on Parkinson's Disease Risk
… health concern, and recent research suggests that exposure to certain toxic chemicals, such as pesticides, may contribute to its development. However, government agencies, such as the US Environmental … a neurotoxic pesticide strongly linked to PD. We will comprehensively analyze the scientific evidence linking …
-
The Michael J. Fox Foundation Collaborates with ESPN Founder Bill Rasmussen to Champion Engagement of Newly Diagnosed Parkinson’s Patients in Research
May 28, 2020
… (MJFF) announced that Bill Rasmussen has joined its team to help speed a cure for Parkinson’s disease. Mr. Rasmussen … on the disease with his signature positive attitude and commitment to staying active, embracing engagement and … of new and better treatments by testing safety and how well they work. But clinical trials and new treatments …
-
Novel JNK Inhibitors as Therapeutic Agents for Parkinson's Disease
… Objective/Rationale: Our objective is to test the in vivo pharmacokinetic profile, mode of action … of JIP1 (JNK-interacting protein 1) but not the ATP-binding site and BI87G9 which binds to both the D-domain of JIP1 and … to stop the progression of PD in humans. Anticipated Outcome: It is anticipated that the proposed studies will …